(Q35782893)

10 August 2017

1 reference

title

Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias (English)

1 reference

10 August 2017

1 reference

Lolita Banerji

1

1 reference

10 August 2017

Martin Sattler

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Therapeutic Targets

10 August 2017

published in

1 reference

10 August 2017

volume

8

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

221-239

1 reference

Studying the pathogenesis of BCR-ABL+ leukemia in mice

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Absence of mutations in the RET gene in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Structural organization of the bcr gene and its role in the Ph' translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Minimal residual disease in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Resistance to targeted therapy in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A myristoyl/phosphotyrosine switch regulates c-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Differential complementation of Bcr-Abl point mutants with c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Signaling from Ras to Rac and beyond: not just a matter of GEFs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Critical role for Gab2 in transformation by BCR/ABL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The role of phosphoinositide 3-kinase lipid products in cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Rho family proteins in cell adhesion and cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Rho GTPases: signaling, migration, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The mouse c-abl locus: molecular cloning and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

An intramolecular SH3-domain interaction regulates c-Abl activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Superoxide and hydrogen peroxide in relation to mammalian cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Cell transformation by the superoxide-generating oxidase Mox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Developmental roles of platelet-derived growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: dependence on lipid rafts for cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Platelet-derived Growth Factor (PDGF) Receptor-α-activated c-Jun NH2-terminal Kinase-1 Is Critical for PDGF-induced p21 Promoter Activity Independent of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Platelet-derived growth factor-mediated signaling through the Shb adaptor protein: effects on cytoskeletal organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Localization of the human stem cell tyrosine kinase-1 gene (FLT3) to 13q12→q13

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Primary structure and functional expression of rat and human stem cell factor DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Mastocytosis and disorders of mast cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Signal transduction by several KIT juxtamembrane domain mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Alternate splicing creates two forms of the human kit protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Src family kinases are involved in the differential signaling from two splice forms of c-Kit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Lipid phosphatases in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Specific inhibition of bcr-abl gene expression by small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Approaches for the sequence-specific knockdown of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Inhibition of kit expression in P815 mouse mastocytoma cells by a hammerhead ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Potential clinical application of antioncogene ribozymes for human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

2-methoxyestradiol alters cell motility, migration, and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

STI-571: an anticancer protein-tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.8.3.221

21 January 2018

Identifiers

DOI

10.1517/14728222.8.3.221

1 reference

10 August 2017

1 reference